We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$2.77M
(+2.4%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
28.33%
Holding
144
New
13
Increased
31
Reduced
53
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Turbine
APPS
|
+$1.3M |
| 2 |
CVSL
CVSL INC. COMMON STOCK
CVSL
|
+$1.29M |
| 3 |
Medtronic
MDT
|
+$1.15M |
| 4 |
Axogen
AXGN
|
+$876K |
| 5 |
Quest Diagnostics
DGX
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$1.47M |
| 2 |
Baxter International
BAX
|
+$1.22M |
| 3 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$993K |
| 4 |
BIOL
Biolase, Inc.
BIOL
|
+$849K |
| 5 |
AIFC
AI Financial Corp
AIFC
|
+$817K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.58% |
| 2 | Technology | 14.17% |
| 3 | Industrials | 9.87% |
| 4 | Miscellaneous | 9.67% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $5.69M | 4.77% |
86,955
+200
| +0.2% | +$13.3K |
|
2
Rockwell Medical
RMTI
$32.2M
| $5.29M | 4.43% |
4,400
+3
| +0.1% | +$3.51K |
|
|
CSII
3
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.88M | 3.26% |
99,500
-3,200
| -3% | -$110K |
|
4
NeoGenomics
NEO
$2.23B
| $3.78M | 3.17% |
809,180
-7,500
| -0.9% | -$32.6K |
|
|
HILL
5
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $3.31M | 2.77% |
623,976
-27,130
| -4% | -$125K |
|
|
SVU
6
DELISTED
SUPERVALU Inc.
SVU
| $2.94M | 2.46% |
36,105
+43
| +0.1% | +$3.08K |
|
|
7
Axogen
AXGN
$2.6B
| $2.28M | 1.91% |
651,050
+255,000
| +64% | +$876K |
|
8
Apple
AAPL
$4.67T
| $2.22M | 1.86% |
71,460
-660
| -0.9% | -$19.9K |
|
9
Pfizer
PFE
$162B
| $2.21M | 1.85% |
67,012
-264
| -0.4% | -$8.39K |
|
|
ASRT
10
DELISTED
Assertio
ASRT
| $2.19M | 1.84% |
1,633
+80
| +5% | +$98.5K |
|
11
Deluxe
DLX
$1.11B
| $2.18M | 1.83% |
31,492
+250
| +0.8% | +$16.3K |
|
12
ePlus
PLUS
$2.4B
| $2.17M | 1.82% |
100,000
| – | – |
|
13
Altimmune
ALT
$665M
| $2.1M | 1.76% |
4,296
-133
| -3% | -$66.3K |
|
14
Xtant Medical Holdings
XTNT
$52.6M
| $1.94M | 1.63% |
39,426
+1,122
| +3% | +$45.1K |
|
15
AtriCure
ATRC
$2.62B
| $1.72M | 1.44% |
84,000
-250
| -0.3% | -$4.84K |
|
|
SQNM
16
DELISTED
SEQUENOM INC NEW
SQNM
| $1.7M | 1.42% |
430,200
+50,000
| +13% | +$184K |
|
|
UPI
17
DELISTED
UROPLASTY INC-NEW
UPI
| $1.66M | 1.39% |
1,360,011
+75,223
| +6% | +$101K |
|
18
UnitedHealth
UNH
$356B
| $1.58M | 1.32% |
13,350
-50
| -0.4% | -$5.55K |
|
19
LeMaitre Vascular
LMAT
$1.84B
| $1.55M | 1.3% |
185,249
-3,700
| -2% | -$29K |
|
|
CNSY
20
Cerenome
CNSY
$20.9M
| – | – |
0
| – | – |
|
21
CVS Health
CVS
$124B
| $1.48M | 1.24% |
14,317
| – | – |
|
22
Eli Lilly
LLY
$1.02T
| $1.47M | 1.23% |
20,200
-250
| -1% | -$17.8K |
|
23
Ionis Pharmaceuticals
IONS
$9.65B
| $1.45M | 1.21% |
22,700
-2,600
| -10% | -$176K |
|
|
ZIXI
24
DELISTED
Zix Corporation
ZIXI
| $1.26M | 1.06% |
321,989
-25,250
| -7% | -$95.7K |
|
|
25
Digital Turbine
APPS
$1.3B
| $1.25M | 1.04% |
+382,004
| New | +$1.3M |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Perkins Capital Management held 144 positions worth $119M, up 2.4% from $117M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Perkins Capital Management's Q1 2015 filing shows 13 new, 31 increased, 53 reduced and 7 closed positions. Its largest new stake was Digital Turbine: 382,004 shares worth $1.25M. The largest sale was HP, an estimated $1.47M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q1 2015 buy was Digital Turbine: 382,004 shares worth $1.25M.
- Perkins Capital Management added most to Axogen in Q1 2015, an estimated $876K increase.
- Perkins Capital Management's biggest Q1 2015 reduction was Baxter International, cutting an estimated $1.22M.
- Perkins Capital Management fully exited HP in Q1 2015, selling an estimated $1.47M.
- Perkins Capital Management's ten largest holdings make up 28% of its $119M portfolio in Q1 2015.
- Perkins Capital Management opened 13 new positions and closed 7 in Q1 2015.
- Perkins Capital Management's portfolio value rose 2.4% quarter-over-quarter to $119M.
Based on Perkins Capital Management's 13F filing for Q1 2015, filed 28 Apr 2015.